ATR and pancreatic neoplasm: A close analogue of VE-821, named VE-822 (or alternatively CX970), with even increased potency against ATR was shown to radiosensitize and chemosensitize pancreatic cancer cells in vitro and pancreatic tumor xenografts in vivo [84].